SCHEMBL20966382

SCHEMBL20966382

CCn1c2ccccc2c2cc(NC(=O)c3cccnc3NCCCN3CCOCC3)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 3/20 0.63
▸ RAC1 P63000 1/20 0.60
▸ MEN1 O00255 12/20 0.55
▸ KMT2A Q03164 12/20 0.55
▸ MAPT P10636 12/20 0.55
▸ KDM4E B2RXH2 5/20 0.55
▸ LMNA P02545 5/20 0.55
▸ ALDH1A1 P00352 4/20 0.55
▸ HPGD P15428 3/20 0.55
▸ NPC1 O15118 2/20 0.55
▸ RAB9A P51151 2/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ GAA P10253 3/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ TDP1 Q9NUW8 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ BLM P54132 1/20 0.51
▸ PTGES O14684 1/20 0.50
▸ RAD52 P43351 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20945434 0.87 RAC1 (0.60) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL20966323 0.84 RAC1 (0.54) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL29920964 0.84 RAC1 (0.54) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL29920894 0.83 NPY5R (0.66) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL20966314 0.83 NPY5R (0.66) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL20945448 0.81 MAPT (0.62) NPY5RMEN1KMT2AMAPTKDM4E
SCHEMBL29920521 0.79 NPY5R (0.68) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL20966399 0.79 NPY5R (0.68) NPY5RRAC1MEN1KMT2AMAPT
SCHEMBL4727570 0.78 NPY5R (1.00) NPY5RMEN1KMT2AMAPTKDM4E
SCHEMBL15087053 0.76 RAC1 (1.00) NPY5RRAC1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2022-09-20 — — US disclosed
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIV PUERTO RICO (US) 2020-11-12 — — US disclosed
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents UNIVERSITY OF PUERTO RICO (US) 2020-08-04 — — US disclosed
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS UNIVERSITY OF PUERTO RICO (PR) 2019-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200352941-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, ARHGDIB NPY5R 4036/4885RAC1 6/4885MEN1 1935/4885
US-11446299-B2 Carbazole EHop-016 derivatives as anticancer and anti-migratory agents CDC42, ARHGEF2, HRAS NPY5R 4104/4885RAC1 7/4885MEN1 1521/4885
US-20190125746-A1 NOVEL CARBAZOLE EHOP-016 DERIVATIVES AS ANTI-CANCER AND ANTI-MIGRATORY AGENTS CDC42, ARHGEF2, HRAS NPY5R 4274/4885RAC1 5/4885MEN1 2021/4885
US-10729689-B2 Carbazole EHop-016 derivatives as anti-cancer and anti-migratory agents CDC42, ARHGEF2, GDI2 NPY5R 4077/4885RAC1 7/4885MEN1 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback